From April 1, 2022 to June 30, 2022, the company has repurchased 79,620 shares, representing 0.03% for CNY 4.86 million. With this, the company has completed the repurchase of 759,620 shares, representing 0.24% for CNY 54.71 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.7 CNY | -2.84% | -3.58% | -6.96% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.96% | 1.69B | |
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
-0.46% | 62.84B | |
+16.09% | 53.34B | |
+0.94% | 48.83B | |
-2.97% | 39.36B | |
+1.23% | 35.73B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.